This review highlights the gut microbiota's role in inflammation and insulin resistance in T2DM, suggesting therapeutic strategies for complication management.
Key Points
Gut microbiota dysbiosis exacerbates inflammation and insulin resistance in type 2 diabetes mellitus.
Key findings indicate that restoring microbial balance may improve glycemic control and reduce complications.
This analysis explored mechanisms connecting microbial dysbiosis and chronic inflammation to T2DM complications.
Potential interventions include probiotics, prebiotics, and fecal microbiota transplantation to enhance management.